Taking a break from hormone-blocking prostate cancer treatments once the cancer seems to be stabilized is not equivalent to continuing therapy, a new large-scale international study finds.
Apr 3, 2013
0
0
University of Southampton biological scientists are leading a major research project aimed at making drugs more effective.
Mar 27, 2013
0
0
As public health authorities across the globe grapple with the growing problem of antibiotic resistance, Tufts University School of Medicine microbiologists and colleagues have identified the unique resistance mechanisms ...
Mar 26, 2013
0
0
(Medical Xpress)—Aggressive drug regimens used to treat multidrug-resistant tuberculosis reduce the risk of death by about 40 percent when they include at least five drugs likely to be effective against a patient's tuberculosis ...
Mar 15, 2013
0
0
As Kenyan citizens negotiated the tensions following the March 4 nationwide elections, memories of the violence that followed the December 2007 vote weighed heavily for many reasons. Among those in any nation with an HIV ...
Mar 12, 2013
0
0
Antibiotic resistance has been recognised in recent years as a major healthcare problem, however, a paper in The Lancet Infectious Diseases reviewing the issue on a global scale, concludes that, not enough attention is given ...
Mar 12, 2013
0
0
Antibiotic resistance "has the potential to undermine modern health systems," argue health economists Richard Smith and Joanna Coast on bmj.com today. They believe that an increase in resistant organisms coupled with a big ...
Mar 11, 2013
0
0
In a recent study, scientists have concluded that the cure rates of Miltefosine, the only oral drug for visceral leishmaniasis available, have significantly decreased. Miltefosine was introduced in the Indian subcontinent ...
Mar 1, 2013
0
0
(HealthDay)—Estrogen treatment at the time of surgical menopause may reverse aspects of pathway-selective insulin resistance in the liver associated with a high-fat diet (HFD) in mice by promoting insulin action on glucose ...
Feb 14, 2013
0
0
An antibody that binds to a molecule on the surface of a rare but deadly tumor of the gastrointestinal tract inhibits the growth of the cancer cells in mice, according to researchers at the Stanford University School of Medicine.
Feb 4, 2013
0
1
